Transition Twins: Sri Lanka and Timor-Leste Team Up for Sustainable Immunization

Over 5,000 kilometres separate Sri Lanka and Timor-Leste, but there are strong parallels between the countries’ two health systems.

Both have lived through recent devastating internal conflict. Both have had to rebuild and reintegrate their health infrastructure. And, in the past two years, both have also transitioned out of Gavi support to take fully responsibility for running and funding their own vaccination programmes.

Similarities stop there.

Find out how the two countries are teaming up to learn and share best practices for sustainable immunization programs in this photo story.

Leave a Reply

Your email address will not be published.

You May Also Like

COVAX Application Materials for AMC Eligible Economies Now Available

The COVAX Facility released the application and guidance documents (“application package”) for eligible economies to (i) confirm participation in the COVAX Facility and (ii) request support as part of COVAX. This comprises COVID-19 vaccines, as well as Cold Chain Equipment and Technical Assistance needed to prepare for the delivery of COVID-19 vaccines.  All 92 AMC Eligible … Continued

COVID-19: Gavi steps up response to pandemic

Gavi, the Vaccine Alliance, will provide US$ 29 million in urgent initial funding to 13 lower-income countries to support their response to COVID-19, helping them to protect health care workers with personal protective equipment (PPE), perform vital surveillance and training, and fund diagnostic tests. There are further requests or interest from 21 countries, meaning more … Continued

Center for Global Development – Global Immunization and Gavi: Five Priorities for the Next Five Years

Below is an excerpt from the Center for Global Development’s overview note.  Child vaccination remains among the most cost-effective uses of public and aid monies.[1] In a highly contested funding environment where priorities must be set for the allocation of scarce concessional resources, investment in expanding the availability and coverage of cost-effective vaccination must come … Continued